Compare TTK HEALTHCARE with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs CIPLA - Comparison Results

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE CIPLA TTK HEALTHCARE/
CIPLA
 
P/E (TTM) x 18.4 22.6 81.2% View Chart
P/BV x 1.5 2.5 59.2% View Chart
Dividend Yield % 1.1 0.6 162.1%  

Financials

 TTK HEALTHCARE   CIPLA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-19
CIPLA
Mar-19
TTK HEALTHCARE/
CIPLA
5-Yr Chart
Click to enlarge
High Rs1,215678 179.2%   
Low Rs610484 126.1%   
Sales per share (Unadj.) Rs444.4198.2 224.2%  
Earnings per share (Unadj.) Rs17.218.5 93.1%  
Cash flow per share (Unadj.) Rs27.635.0 79.0%  
Dividends per share (Unadj.) Rs5.003.00 166.7%  
Dividend yield (eoy) %0.50.5 106.1%  
Book value per share (Unadj.) Rs177.9186.3 95.5%  
Shares outstanding (eoy) m14.13805.70 1.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.12.9 70.1%   
Avg P/E ratio x52.931.4 168.7%  
P/CF ratio (eoy) x33.016.6 198.9%  
Price / Book Value ratio x5.13.1 164.5%  
Dividend payout %29.016.2 179.0%   
Avg Mkt Cap Rs m12,894468,031 2.8%   
No. of employees `0002.322.6 10.2%   
Total wages/salary Rs m1,30728,565 4.6%   
Avg. sales/employee Rs Th2,715.77,053.1 38.5%   
Avg. wages/employee Rs Th565.31,261.5 44.8%   
Avg. net profit/employee Rs Th105.4659.1 16.0%   
INCOME DATA
Net Sales Rs m6,279159,710 3.9%  
Other income Rs m784,766 1.6%   
Total revenues Rs m6,356164,475 3.9%   
Gross profit Rs m49630,973 1.6%  
Depreciation Rs m14713,263 1.1%   
Interest Rs m341,684 2.0%   
Profit before tax Rs m39320,791 1.9%   
Minority Interest Rs m0-172 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1495,695 2.6%   
Profit after tax Rs m24414,924 1.6%  
Gross profit margin %7.919.4 40.7%  
Effective tax rate %37.927.4 138.5%   
Net profit margin %3.99.3 41.5%  
BALANCE SHEET DATA
Current assets Rs m2,717124,266 2.2%   
Current liabilities Rs m1,57137,715 4.2%   
Net working cap to sales %18.354.2 33.7%  
Current ratio x1.73.3 52.5%  
Inventory Days Days3291 35.5%  
Debtors Days Days4795 49.2%  
Net fixed assets Rs m991105,190 0.9%   
Share capital Rs m1411,611 8.8%   
"Free" reserves Rs m2,373148,511 1.6%   
Net worth Rs m2,514150,123 1.7%   
Long term debt Rs m338,301 0.0%   
Total assets Rs m4,158239,633 1.7%  
Interest coverage x12.613.3 94.5%   
Debt to equity ratio x00.3 0.5%  
Sales to assets ratio x1.50.7 226.6%   
Return on assets %6.76.9 96.3%  
Return on equity %9.79.9 97.5%  
Return on capital %16.911.8 143.1%  
Exports to sales %3.634.7 10.3%   
Imports to sales %0.50-   
Exports (fob) Rs m22555,419 0.4%   
Imports (cif) Rs m31NA-   
Fx inflow Rs m22557,410 0.4%   
Fx outflow Rs m7119,041 0.4%   
Net fx Rs m15438,368 0.4%   
CASH FLOW
From Operations Rs m17316,911 1.0%  
From Investments Rs m97-16,687 -0.6%  
From Financial Activity Rs m-307-3,487 8.8%  
Net Cashflow Rs m-38-3,451 1.1%  

Share Holding

Indian Promoters % 65.4 16.0 408.8%  
Foreign collaborators % 0.0 20.8 -  
Indian inst/Mut Fund % 3.7 12.2 30.3%  
FIIs % 5.2 23.7 21.9%  
ADR/GDR % 0.0 1.1 -  
Free float % 25.8 26.2 98.5%  
Shareholders   12,723 161,166 7.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   DR. REDDYS LAB  PIRAMAL ENTERPRISES  JUBILANT LIFE SCIENCES  SUN PHARMA  PFIZER  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

CIPLA Announces Quarterly Results (2QFY20); Net Profit Up 31.2% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, CIPLA has posted a net profit of Rs 5 bn (up 31.2% YoY). Sales on the other hand came in at Rs 44 bn (up 9.6% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2018-19 Annual Report Analysis (Annual Result Update)

Sep 9, 2019 | Updated on Sep 9, 2019

Here's an analysis of the annual report of CIPLA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CIPLA Announces Quarterly Results (1QFY20); Net Profit Up 5.6% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CIPLA has posted a net profit of Rs 5 bn (up 5.6% YoY). Sales on the other hand came in at Rs 40 bn (up 1.3% YoY). Read on for a complete analysis of CIPLA's quarterly results.

TTK HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 53.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, TTK HEALTHCARE has posted a net profit of Rs 36 m (down 53.8% YoY). Sales on the other hand came in at Rs 2 bn (up 3.2% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

TTK HEALTHCARE 2018-19 Annual Report Analysis (Annual Result Update)

Jul 18, 2019 | Updated on Jul 18, 2019

Here's an analysis of the annual report of TTK HEALTHCARE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TTK HEALTHCARE. Also includes updates on the valuation of TTK HEALTHCARE.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Nov 15, 2019 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS